monoclonal antibody Me1-14 F(ab')2

BIOLOGICAL2 trials

Sponsors

Duke University

Conditions

Brain and Central Nervous System TumorsMelanoma (Skin)Metastatic Cancer

Phase 1

Monoclonal Antibody Therapy in Treating Patients With Brain Metastases

CompletedNCT00002751

Duke UniversityMetastatic Cancer

Start: 1989-07-31End: 2004-05-31Target: 6Updated: 2013-06-20

Monoclonal Antibody Therapy in Treating Patients With Primary or Metastatic Melanoma or Brain Tumors

CompletedNCT00002754

Duke UniversityBrain and Central Nervous System Tumors, Melanoma (Skin), Metastatic Cancer

Start: 1993-02-28End: 2001-04-30Target: 6Updated: 2013-02-20